Mitiglinide

米格列奈钙

Report date: 2022/05/12 17:24:51
NME

Base Information

Drug NameMitiglinide
Drug Alias Name米格列奈mitiglinidaMitiglinidumMitiglinide Calcium HydrateGlinsuna +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockersVoltage-gated potassium channel blockers
TargetsPotassium channelVoltage-gated potassium channel
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryJapan
Original Approved Date2004/01/29
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesKissei Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJw Pharmaceutical CorpElixir Pharmaceuticals IncEisai Co Ltd +[5] 
Inactive CompaniesKissei Pharmaceutical Co Ltd
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeA10BX08
Related LinksWikipediaDrugBankKEGG